Clinical significance of SQSTM1/P62 and nuclear factor-κB expression in pancreatic carcinoma

Table 2 Relationships between the positive expression of phosph-P65 and clinicopathological features in pancreatic carcinomas (n = 35)

Clinicopathological feature	n	Phosph-P65		P value1
		+++	++
Gender	35	16	19	0.678
Male	21	9	12
Female	14	7	7
Age (yr)				0.508
< 60	22	11	11
≥ 60	13	5	8
Pathology type				0.181
Duct adenocarcinoma	27	14	13
Adenocarcinoma	8	2	6
T stage				0.027
T0	0	0	0
T1	1	0	1
T2	9	1	8
T3	25	15	10
T4	0	0	0
N stage				0.446
N0	32	14	18
N1	3	2	1
N2	0	0	0
N3	0	0	0
M stage				0.352
M0	34	16	18
M1	1	0	1
TNM stage				0.006
I	11	1	10
II	23	15	8
III	0	0	0
IV	1	0	1

¹Pearson χ². TNM: Tumor-node-metastasis.